Genmab A/S (GMAB)
NASDAQ: GMAB
· Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT
Genmab A/S Balance Sheet Statement
Financials in DKK. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.62B | 9.86B | 6.34B | 4.33B | 14.67B | 14.87B | 14.27B | 10.87B | 12.29B | 9.89B | 10.38B | 9.82B | 9.07B | 8.96B | 8.73B | 9.48B | 7.89B |
Short-Term Investments | 1.61B | 11.24B | 10.98B | 11.4B | 14.91B | 13.27B | 13.25B | 14.01B | 12.26B | 12.43B | 13.41B | 11.8B | 10.92B | 10.38B | 10.01B | 8.4B | 10.19B |
Long-Term Investments | 30M | 228M | 189M | 196M | 153M | 134M | 156M | 183M | 140M | 133M | 155M | 201M | 239M | 371M | 587M | 753M | 905M |
Other Long-Term Assets | 8M | 52M | 60M | 77M | 63M | 62M | 37M | 31M | 43M | 48M | 39M | 66M | 27M | 27M | 33M | 33M | 32M |
Receivables | 799M | 6.69B | 6.31B | 6.17B | 4.68B | 4.95B | 5.43B | 4.81B | 3.2B | 5.71B | 4.95B | 3.88B | 2.85B | 3.37B | 3.21B | 2.43B | 1.85B |
Inventory | 12M | 62M | 71M | 36M | 106M | 57M | 70M | 51M | -488M | -143M | n/a | n/a | -341M | -31M | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 124M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 4.04B | 27.85B | 23.7B | 21.94B | 34.37B | 33.14B | 33.03B | 29.75B | 28.23B | 28.38B | 28.74B | 25.49B | 23.18B | 22.74B | 21.95B | 20.3B | 19.94B |
Property-Plant & Equipment | 271M | 1.89B | 1.8B | 1.88B | 1.86B | 1.64B | 1.65B | 1.63B | 1.6B | 1.32B | 1.29B | 1.24B | 975M | 975M | 957M | 919M | 842M |
Goodwill & Intangibles | 2.11B | 14.88B | 13.91B | 14.53B | 23M | 101M | 115M | 129M | 132M | 146M | 200M | 216M | 234M | 254M | 275M | 297M | 317M |
Total Long-Term Assets | 2.55B | 17.96B | 15.96B | 16.68B | 2.31B | 2.15B | 2.21B | 2.23B | 2.16B | 1.9B | 1.95B | 1.99B | 1.74B | 1.89B | 2.03B | 2.18B | 2.27B |
Total Assets | 6.59B | 45.81B | 39.66B | 38.62B | 36.68B | 35.29B | 35.24B | 31.98B | 30.39B | 30.28B | 30.69B | 27.48B | 24.91B | 24.63B | 23.98B | 22.48B | 22.21B |
Account Payables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.83B | 1.72B | n/a | n/a | 1.25B | 350M | n/a | n/a | n/a |
Deferred Revenue | 6M | 24M | 39M | 33M | 33M | 33M | 33M | 33M | 33M | 33M | 33M | 26M | 26M | 26M | 26M | 26M | 26M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39M | 32M | n/a | 860M | n/a | n/a | n/a |
Total Current Liabilities | 756M | 5.31B | 4.58B | 4.36B | 2.76B | 2.48B | 2.9B | 1.99B | 1.96B | 1.82B | 2.99B | 1.94B | 1.34B | 1.57B | 1.83B | 1.35B | 1.29B |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 5M | 30M | 29M | 28M | 26M | 515M | 514M | 29M | 509M | 491M | 491M | 496M | 500M | 500M | 496M | 496M | 496M |
Total Long-Term Liabilities | 534M | 3.81B | 3.15B | 3.29B | 1.42B | 1.2B | 1.22B | 1.23B | 1.25B | 1.01B | 1.04B | 1.05B | 856M | 863M | 870M | 880M | 822M |
Total Liabilities | 1.29B | 9.11B | 7.74B | 7.65B | 4.18B | 3.68B | 4.13B | 3.22B | 3.2B | 2.84B | 4.03B | 2.99B | 2.19B | 2.43B | 2.7B | 2.23B | 2.12B |
Total Debt | 143M | 1.03B | 987M | 1.02B | 1.01B | 770M | 793M | 803M | 829M | 597M | 629M | 634M | 416M | 425M | 437M | 443M | 378M |
Common Stock | 10M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M | 66M |
Retained Earnings | 3.54B | 23.55B | 19.62B | 18.13B | 19.8B | 19.02B | 18.45B | 16.16B | 14.67B | 14.97B | 14.3B | 12.24B | 10.51B | 10.02B | 9.14B | 8.16B | 8.02B |
Comprehensive Income | -213M | 490M | -346M | 234M | 108M | 60M | 142M | 112M | 117M | 98M | 151M | 110M | 97M | 81M | 84M | 82M | 95M |
Shareholders Equity | 5.3B | 36.7B | 31.92B | 30.97B | 32.5B | 31.61B | 31.11B | 28.75B | 27.19B | 27.44B | 26.66B | 24.48B | 22.72B | 22.2B | 21.29B | 20.25B | 20.09B |
Total Investments | 1.64B | 11.47B | 11.16B | 11.6B | 15.07B | 13.46B | 13.41B | 14.19B | 12.4B | 12.56B | 13.57B | 12B | 11.16B | 10.75B | 10.6B | 9.15B | 11.1B |